Synthesis and Insight into the Structure-activity Relationships of 2-phenylbenzimidazoles As Prospective Anticancer Agents
Overview
Affiliations
In order to explore and develop new anticancer agents, three series of 2-phenylbenzimidazoles, 15-46, were condensed under simple and mild conditions using sodium metabisulfite as an oxidation agent and another series, 47-55, were obtained a reduction reaction using sodium borohydride. All the compounds synthesized were evaluated for their anticancer activities against three human cancer cell lines. The novel compound 38 was found to be the most potent multi cancer inhibitor against A549, MDA-MB-231, and PC3 cell lines (IC values 4.47, 4.68 and 5.50 μg mL, respectively). In addition, compound 40 exhibited the best IC value of 3.55 μg mL against the MDA-MB-231 cell line. The results demonstrated that introducing a new substituent to compounds 37-55 could improve their antiproliferative activities.
Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016-2023).
Hagar F, Abbas S, Atef E, Abdelhamid D, Abdel-Aziz M Mol Divers. 2024; 29(2):1821-1849.
PMID: 39031290 DOI: 10.1007/s11030-024-10907-8.
Study, Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives.
Karthick K, Abishek K, Angel Jemima E Bioinform Biol Insights. 2024; 18:11779322241247635.
PMID: 38854784 PMC: 11159556. DOI: 10.1177/11779322241247635.
Isik A, Acar Cevik U, Karayel A, Ahmad I, Patel H, Celik I ACS Omega. 2024; 9(16):18469-18479.
PMID: 38680334 PMC: 11044166. DOI: 10.1021/acsomega.4c00543.
Nguyen V, Huynh T, Ho G, Nguyen T, Le Anh Nguyen T, Dao D R Soc Open Sci. 2022; 9(9):220659.
PMID: 36147940 PMC: 9490329. DOI: 10.1098/rsos.220659.